Cargando…

The contributions of hypoxia to poor outcomes in pancreatic cancer

Detalles Bibliográficos
Autor principal:	Bijlsma, Maarten F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745382/ https://www.ncbi.nlm.nih.gov/pubmed/36523300 http://dx.doi.org/10.21037/tcr-22-2167

Ejemplares similares

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
por: Manoukian, Paul, et al.
Publicado: (2021)

Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes
por: Kashani, Kianoush B.
Publicado: (2020)

The case for a stratified application of targeted agents against pancreatic cancer
por: Bijlsma, Maarten F.
Publicado: (2021)

Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
por: Hindriksen, Sanne, et al.
Publicado: (2012)

Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer
por: Ino, Yoshinori, et al.
Publicado: (2013)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018)

Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness
por: Vasseur, Sophie, et al.
Publicado: (2010)

Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer
por: Veenstra, Veronique L., et al.
Publicado: (2018)

Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer
por: Berg, Anna, et al.
Publicado: (2016)

Hypoxia-Induced miR-148a Downregulation Contributes to Poor Survival in Colorectal Cancer
por: Nersisyan, Stepan, et al.
Publicado: (2021)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022)

Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion
por: Tekin, Cansu, et al.
Publicado: (2020)

Asymptomatic hypoxia in COVID-19 is associated with poor outcome
por: Brouqui, Philippe, et al.
Publicado: (2021)

The metabolic facet of pancreatic cancer: How hypoxia shapes fatal cancer cells
por: Guillaumond, Fabienne, et al.
Publicado: (2013)

STIM1 overexpression in hypoxia microenvironment contributes to pancreatic carcinoma progression
por: Wang, Jian, et al.
Publicado: (2019)

Hypoxia and Cancer: From Bench to Bedside
por: Wang, Lingzhi, et al.
Publicado: (2023)

Hyponatremia in acute heart failure: a marker of poor condition or a mediator of poor outcome?
por: Bae, Myung Hwan, et al.
Publicado: (2015)

Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview
por: Slapak, Etienne J., et al.
Publicado: (2022)

Migratory gene expression signature predicts poor patient outcome: Are cancer stem cells to blame?
por: Wicha, Max S
Publicado: (2012)

Hypoxia in the Gut
por: Taylor, Cormac T.
Publicado: (2017)

Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer
por: Slapak, Etienne J., et al.
Publicado: (2023)

Textbook outcomes in hepatobiliary and pancreatic surgery
por: Tsilimigras, Diamantis I, et al.
Publicado: (2021)

MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis
por: Xu, Jianwei, et al.
Publicado: (2014)

Pancreatic Cancer
por: Funel, Niccola, et al.
Publicado: (2015)

What Is the Next in Developing Model to Predict Survival Outcomes of Resected Pancreatic Cancer?
por: Kang, Chang Moo
Publicado: (2021)

ADAM9-Responsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery in Pancreatic Cancer
por: Slapak, Etienne J., et al.
Publicado: (2021)

Stromal SPOCK1 supports invasive pancreatic cancer growth
por: Veenstra, Veronique L., et al.
Publicado: (2017)

Hypoxia metabolism in ageing
por: Valli, Alessandro, et al.
Publicado: (2015)

Hypoxia and glioblastoma therapy
por: Yang, Chunzhang, et al.
Publicado: (2015)

Special issue on hypoxia
por: Yeo, Eui-Ju
Publicado: (2019)

Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation
por: Duitman, JanWillem, et al.
Publicado: (2021)

Why cachexia kills: examining the causality of poor outcomes in wasting conditions
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2013)

PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer
por: Tekin, Cansu, et al.
Publicado: (2018)

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer
por: Duffy, John P, et al.
Publicado: (2003)

Targeting the hypoxia pathway to treat pancreatic cancer
por: Erickson, Lori A, et al.
Publicado: (2015)

The impact of hypoxia in pancreatic cancer invasion and metastasis
por: Yuen, Angela, et al.
Publicado: (2014)

The Contribution of Health Behaviors to Depression Risk Across Birth Cohorts
por: Gueltzow, Maria, et al.
Publicado: (2022)

Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?
por: Slapak, Etienne J., et al.
Publicado: (2020)

Sirtainties in pancreatic cancer?
por: Rooman, Ilse
Publicado: (2014)

Pancreatic cancer surgery
por: Di Martino, Marcello, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ro8j760f5u3fai72r8cn0k7rgg